Shady A. Swidan

cairo university

H指数:15

被引数:705

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Reprogramming hepatocellular carcinoma: Nanomedicine at the crossroads of molecular targets and smart delivery

重编程肝细胞癌：纳米医学在分子靶点与智能递送交汇处的应用

COLLOIDS AND SURFACES B-BIOINTERFACES

IF5.6

2026-07-010

PRE

Ionic liquid-coated Eudragit RS nanoparticles for topical delivery of honokiol to remodel the hair follicle microenvironment in androgenic alopecia

离子液体包覆的Eudragit RS纳米粒子用于局部递送和厚朴酚以重塑雄激素性脱发中的毛囊微环境

International Journal of Pharmaceutics

IF5.2

2026-06-010

PRE

Controlled release 3D nanofiber scaffolds for fostering the anti-acne effect of spironolactone in an in vivo surgical testosterone-induced acne model

控释3D纳米纤维支架用于促进螺内酯在体内手术睾酮诱导痤疮模型中的抗痤疮效果

International Journal of Pharmaceutics

IF5.2

2025-09-230

PRE

Silibinin-loaded cubosomes: a gateway to enhanced hepatoprotective activity

Silibinin负载的cubosomes：增强肝保护活性的途径

Future Journal of Pharmaceutical Sciences

IF3

2025-06-230

Enhancing Polyacrylonitrile Nanofibers Antiviral Activity Using Greenly Synthesized Silver Nanoparticles

利用绿色合成法制备的银纳米粒子增强聚丙烯腈纳米纤维的抗病毒活性

ARCHIV DER PHARMAZIE

IF3.6

2025-04-011

PRE

Size-optimized simvastatin-loaded TPGS modified lipid nanocapsules for targeting epithelial-to-mesenchymal transition in hepatocellular carcinoma: Role of PTEN/AKT signaling

EXPERT OPINION ON DRUG DELIVERY

IF5.4

2023-05-304

PRE

Cerium Oxide Nanoparticles/Polyacrylonitrile Nanofibers as Impervious Barrier against Viral Infections

PHARMACEUTICS

IF5.5

2023-05-1311

OAAI

Development, Optimization, and In Vitro/In Vivo Evaluation of Azelaic Acid Transethosomal Gel for Antidermatophyte Activity

ANTIBIOTICS-BASEL

IF4.6

2023-04-0512

Fabrication and characterization of anti-rosacea 3D nanofibrous customized sheet masks as a novel scaffold for repurposed use of spironolactone with pre-clinical studies

INTERNATIONAL JOURNAL OF PHARMACEUTICS

IF5.2

2023-04-013

PRE

Exploring the potential of intranasally administered naturally occurring quercetin loaded into polymeric nanocapsules as a novel platform for the treatment of anxiety

SCIENTIFIC REPORTS

IF3.9

2023-01-107

OAAI

Characterization, antibacterial, antioxidant, antidiabetic, and anti-inflammatory activities of green synthesized silver nanoparticles using Phragmanthera austroarabica A. G. Mill and J. A. Nyberg extract

使用Phragmanthera austroarabica A的绿色合成银纳米颗粒的表征，抗菌，抗氧化，抗糖尿病和抗炎活性。吉。米尔和J.A.Nyberg提取物

FRONTIERS IN MICROBIOLOGY

IF4.5

2023-01-0518

OAAI

Comparative Cytotoxic Evaluation of Zygophyllum album Root and Aerial Parts of Different Extracts and Their Biosynthesized Silver Nanoparticles on Lung A549 and Prostate PC-3 Cancer Cell Lines

PHARMACEUTICALS

IF4.8

2022-10-285

OAAI

Comparative Estimation of the Cytotoxic Activity of Different Parts of Cynara scolymus L.: Crude Extracts versus Green Synthesized Silver Nanoparticles with Apoptotic Investigation

PHARMACEUTICS

IF5.5

2022-10-136

OAAI

Silver Nanoparticles Formulation of Flower Head's Polyphenols of Cynara scolymus L.: A Promising Candidate against Prostate (PC-3) Cancer Cell Line through Apoptosis Activation

MOLECULES

IF4.6

2022-09-247

OAAI

Lipid based nanoparticles as a novel treatment modality for hepatocellular carcinoma: a comprehensive review on targeting and recent advances

JOURNAL OF NANOBIOTECHNOLOGY

IF12.6

2022-03-0548

OAAI

Green Synthesized Honokiol Transfersomes Relieve the Immunosuppressive and Stem-Like Cell Characteristics of the Aggressive B16F10 Melanoma

INTERNATIONAL JOURNAL OF NANOMEDICINE

IF6.5

2021-08-0118

OAAI

Design, Synthesis, Anticancer Activity, and Solid Lipid Nanoparticle Formulation of Indole- and Benzimidazole-Based Compounds as Pro-Apoptotic Agents Targeting Bcl-2 Protein

PHARMACEUTICALS

IF4.8

2021-02-0122

OAAI

Celecoxib Loaded In-Situ Provesicular Powder and Its In-Vitro Cytotoxic Effect for Cancer Therapy: Fabrication, Characterization, Optimization and Pharmacokinetic Evaluation

PHARMACEUTICS

IF5.5

2020-11-289

OAAI

Quality by Design for the Development and Analysis of Enhanced In-Situ Forming Vesicles for the Improvement of the Bioavailability of Fexofenadine HCl In Vitro and In Vivo

PHARMACEUTICS

IF5.5

2020-04-2916

OAAI

Trazodone Loaded Lipid Core Poly (ε-caprolactone) Nanocapsules: Development, Characterization and in Vivo Antidepressant Effect Evaluation

SCIENTIFIC REPORTS

IF3.9

2020-02-0615

OAAI

Shady A. Swidan

个人简介

教育背景

工作经历

荣誉奖项

研究方向